Lunai Bioworks (LNAI) Interest Expenses (2012 - 2026)
Lunai Bioworks (LNAI) posted quarterly Interest Expenses of $108052.0 for Q1 2026, down 42.73% year-over-year from $188685.0 in Q1 2025, and down 11.07% quarter-over-quarter from $121508.0 in Q4 2025.
Lunai Bioworks (LNAI) Interest Expenses (2012 - 2026) Analysis & Trends
Lunai Bioworks' Interest Expenses history runs 15 years deep, the most recent figure standing at $108052.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 42.73% year-over-year to $108052.0; the TTM figure through Mar 2026 stood at -$161141.0 (up 19.54% YoY), while the FY2025 annual figure was $83.7 million, down 51.06% from the prior year.
- Interest Expenses for Q1 2026 stood at $108052.0, down from $121508.0 in the prior quarter.
- The five-year high for Interest Expenses was $349204.0 in Q1 2024, with the low at -$737929.0 in Q2 2024.
- The 5-year median for Interest Expenses is $121508.0 (2025), against an average of $50797.8.
- Peak annual rise in Interest Expenses reached 185.56% in 2024, while the deepest fall reached 673.14% in 2024.
- Lunai Bioworks' Interest Expenses stood at $96581.0 in 2022, then surged by 184.72% to $274984.0 in 2023, then plunged by 64.04% to $98891.0 in 2024, then gained by 22.87% to $121508.0 in 2025, then dropped by 11.07% to $108052.0 in 2026.
- Business Quant data shows LNAI's Interest Expenses at $108052.0 in Q1 2026, $121508.0 in Q4 2025, and $122400.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 108,052.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,052.00 |
| Mar 31, 2026 | 108,052.00 |
| Dec 31, 2025 | 121,508.00 |
| Dec 31, 2025 | 121,508.00 |
| Sep 30, 2025 | 122,400.00 |
| Sep 30, 2025 | 122,400.00 |
| Jun 30, 2025 | -513,101.00 |
| Jun 30, 2025 | -513,101.00 |
| Mar 31, 2025 | 188,685.00 |
| Mar 31, 2025 | 188,685.00 |
| Dec 31, 2024 | 98,891.00 |
| Dec 31, 2024 | 98,891.00 |
| Sep 30, 2024 | 250,080.00 |
| Sep 30, 2024 | 250,080.00 |
| Jun 30, 2024 | -737,929.00 |
| Jun 30, 2024 | -737,929.00 |
| Mar 31, 2024 | 349,204.00 |
| Mar 31, 2024 | 349,204.00 |
| Dec 31, 2023 | 274,984.00 |
| Dec 31, 2023 | 274,984.00 |